The clinical significance of POLG gene polymorphism by Krausz, Csilla Gabriella et al.
20 December 2021
The clinical significance of POLG gene polymorphism / KRAUSZ C.; GUARDUCCI E.; BECHERINI L.;
DEGL'INNOCENTI S.; GERACE L.; BALERCIA G.; FORTI G.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY
AND METABOLISM. - ISSN 0021-972X. - STAMPA. - 89(2004), pp. 4292-4297.
Original Citation:
The clinical significance of POLG gene polymorphism
Terms of use:
Publisher copyright claim:
(Article begins on next page)
La pubblicazione è resa disponibile sotto le norme e i termini della licenza di deposito, secondo quanto stabilito dalla
Policy per l'accesso aperto dell'Università degli Studi di Firenze (https://www.sba.unifi.it/upload/policy-oa-2016-1.pdf)
Availability:
This version is available at: 2158/313923 since: 2019-07-23T16:46:43Z
Questa è la Versione finale referata (Post print/Accepted manuscript) della seguente pubblicazione:
FLORE
Repository istituzionale dell'Università degli Studi di
Firenze
Open Access
The Clinical Significance of the POLG Gene
Polymorphism in Male Infertility
C. KRAUSZ, E. GUARDUCCI, L. BECHERINI, S. DEGL’INNOCENTI, L. GERACE, G. BALERCIA, AND
G. FORTI
Department of Clinical Physiopathology, Andrology Unit (C.K., E.G., L.B., S.d.’I., G.F.), University of Florence, 50139
Firenze, Italy; Molecular Biology Support Laboratory (L.G.), Applied Biosystems, Monza, Italy; and Division of
Endocrinology (G.B.), Institute of Internal Medicine Polytechnic University of Marche, Ancona, Italy
Based on association studies, an increasing number of gene
polymorphisms have been proposed as modulators of sper-
matogenesis. Interestingly, a clear cause-effect relationship
between a polymorphism of the POLG gene and oligo(asthe-
no)zoospermia was recently described. The POLG gene con-
tains a polymorphic CAG repeat, and the presence of a ho-
mozygous mutant (not10/not10 CAG) genotype was found only
in infertile men. In the present study, a large number of in-
fertile patients and normospermic men of Italian origin were
studied to define the effect of POLG genotypes on spermato-
genic potential and whether the homozygous mutant is spe-
cific for spermatogenic disturbances. The mutated genotype
was found at the same frequency in both infertile and nor-
mospermic men. Mean values of sperm parameters such as
sperm count, motility, and morphology did not differ signif-
icantly between carriers of the three different genotypes. Our
study failed to confirm any influence of the POLG gene poly-
morphism on the efficiency of the spermatogenesis. More im-
portantly, considering that the homozygous mutant genotype
has been found in normospermic fertile men, the analysis of
the CAG repeat tract of the POLG gene does not appear to have
any clinical diagnostic value. (J Clin Endocrinol Metab 89:
4292–4297, 2004)
INFERTILITY/SUBFERTILITY ALREADY affects about5–7% of the general male population and may further
increase in the future, considering an apparent trend of de-
clining sperm count in industrialized countries over the last
40–50 yr (1, 2). Abnormal sperm parameters (oligoasthe-
noteratozoospermia) or absence of spermatozoa in the ejac-
ulate (azoospermia) are mainly related (75%) to primitive
testicular damage, whereas obstructive (posttesticular) and
central or secondary (pretesticular) forms are relatively rare
(3). Despite our increasing knowledge of the physiology of
male reproduction and the availability of new diagnostic
tools, the etiopathogenesis of testicular failure remains un-
defined in about 50% of cases, which are referred to as id-
iopathic infertility.
These idiopathic cases are likely to be of genetic origin
because the number of genes involved in human spermat-
ogenesis is probably over thousands (4), and only a small
proportion of them have been identified and screened in
infertile men so far.
Chromosomal anomalies (mainly numerical, such as
Klinefelter syndrome) and microdeletions of the azoosper-
mia factor (AZF) regions of the Y chromosome (5–7) are the
most frequent known genetic causes of spermatogenic fail-
ure. The frequency of these two genetic anomalies increases
with the severity of the spermatogenic defect, reaching to an
overall 30% (15% karyotype abnormalities and 15% of AZF
microdeletions) in azoospermic men. Besides these relatively
frequent causes, mutations in specific genes such as KALIG-1
(8), KALIG-2 (FGFR-1) (9), GPR54 (10), GnRH receptor (11),
gonadotropins (12), gonadotropin receptors (13), and andro-
gen receptor (14) have also been identified in patients af-
fected by syndromic hypogonadism or in patients with a
characteristic picture of hormonal abnormalities. Mutation
analyses in spermatogenesis candidate genes revealed an
extremely low incidence, for instance in the USP9Y gene
(15), or no functionally relevant mutations in the DBY (15),
DAZLA (16), or FATE genes (17).
More recently, a number of reports have focused upon the
role of certain haplogroups, allele variants, and single-
nucleotide polymorphisms in male infertility. Based on as-
sociation studies, an increasing number of gene polymor-
phisms have been proposed as modulators of the efficiency
of the spermatogenic process leading to moderate or severe
impairment of sperm production. In many cases, only spo-
radic data are available: polymorphisms in the genes DAZLA
(16), DAZ (18), protamine-2 (19), estrogen receptor  (20),
P450–1A1 (21), and mtDNA haplogroups (22); whereas re-
sults for CAG repeat-length polymorphism in the androgen
receptor gene are discordant among different studies (for
review, see Ref. 23). Association studies concerning human
histocompatibility leukocyte antigen haplotypes (24, 25) rep-
resent an important starting point for the search of major
histocompatibility complex genes involved in spermatogen-
esis. Similarly, a Y chromosome effect on spermatogenesis
(other than AZF deletions) can be determined indirectly by
the definition of Y chromosome haplogroups predisposing to
male infertility (26).
Although Klinefelter sdr, Y microdeletions, and some of
the gene-specific mutations are specific for spermatogenic
Abbreviations: AZF, Azoospermia factor; mtDNA, mitochondrial
DNA.
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failure and, thus, not found in normozoospermic men, the
above-listed polymorphisms must be considered risk factors
given their presence (although at a lower frequency) in fertile
(normospermic) men.
Interestingly, a clear cause-effect relationship between a
polymorphism of the gene of POLG and oligo(astheno)zo-
ospermia has recently been described by Rovio et al. (27). The
POLG gene contains a polymorphic CAG repeat with a major
allele at 10 CAG in the general population. Many repeat-
length alleles different from 10 (ranging from 6–15) have
been found and are considered mutants. Rovio et al. (27)
reported the presence of homozygous mutant (not10/not10
CAG) genotype in infertile males (nine of 99) but not in fertile
men (zero of 98), suggesting a new genetic cause of male
infertility. The authors hypothesized that the presence of two
mutated alleles would lead to a suboptimal mtDNA poly-
merase resulting in the accumulation of mutations in the
mtDNA that would cause impaired energy metabolism of the
spermatogenic cells and finally a disturbance of sperm pro-
duction and/or differentiation.
The aim of the present study was to assess whether dif-
ferent CAG allele genotypes are associated with different
spermatogenic potential and whether the not10/not10 CAG
genotype is specific for spermatogenic disturbances, and,
thus, whether the screening for POLG polymorphism can be
proposed as new diagnostic test. A large number of infertile
patients with different sperm count (ranging from azoosper-
mia to mild forms of oligozoospermia) and a control group
of normospermic men of Italian origin have been studied.
Subjects and Methods
Subjects
The study population consisted of 245 patients seeking complete
andrological work-up for couple infertility at the Andrology Unit and
the Unit of Physiopathology of Reproduction of the University Hospital
Careggi (Florence, Italy). All patients underwent comprehensive andro-
logical examination including semen analysis and karyotype and Y
chromosome microdeletion screening. A total of 50 patients were ex-
cluded because of the presence of karyotype/Y chromosome anomalies
(n  21), hypogonadotrophic hypogonadism (n  3), iatrogenic causes
(n  6), and patients of non-Italian origin (n  20).
Of the 195 patients included in this study, sperm count revealed
azoospermia (the complete absence of spermatozoa) in 50 patients, cryp-
tozoospermia (1 million spermatozoa/ml) in 25 patients, severe oli-
gozoospermia (1–5 million spermatozoa/ml) in 72 patients, moderate
oligozoospermia (5–20 million spermatozoa/ml) in 33 patients, asthe-
noteratozoospermia (total progressive motility  50% with total normal
morphology  30%) in 11 patients, and pure teratozoospermia in four
patients.
A total of 190 men with normal sperm parameters have been recruited
from the Florence and Ancona areas. Ninety men fathered at least one
child or had normal fertilization after in vitro fertilization for pure tubal
factor infertility. All subjects gave an informed consent for molecular
analysis of their blood samples.
Semen analysis
Semen analysis has been performed, according to the 1992 World
Health Organization guidelines (28), at the Andrology Laboratory of the
University Hospital of Careggi (Florence, Italy).
Molecular analysis
DNA source. DNA was extracted from peripheral lymphocytes in the
infertile group and in 130 controls, whereas DNA was isolated from
frozen semen in 60 controls.
CAG repeat-length analysis. The CAG-repeat region of the POLG gene was
amplified by PCR according to Rovio et al. (29). The CAG repeat-length
analysis was performed using an autosequencer (ABI PRISM 310; Ap-
plied Biosystems, Foster City, CA). The size of the PCR products was
determined by GeneScan software (Applied Biosystems). CAG repeat
regions with different CAG repeat numbers were subjected to direct
sequencing on the autosequencer for the definition of the correct CAG
repeat length. The number of CAG repeats was calculated, using
GeneScan software, by comparing the detected PCR fragment with the
sequenced fragments. CAG repeat number determination was repeated
twice on two separate gel runs.
Each homozygous mutant (not10 CAG) sample was confirmed by
direct sequencing.
Statistical analysis
Statistical analysis was performed using the statistical package SPSS
for Windows (version 11; SPSS Inc. Chicago, IL). All variables were
checked for normal distribution by Kolmogorov-Smirnov one-sample
test.
For comparisons of means between groups of different genotypes,
Student’s t test for independent samples, when normal distribution was
observed, was applied. Logarithmic transformation of data was per-
formed to normalize the distribution when the presence of log normal
distribution was checked. Finally, in the case of nonnormalized distri-
bution, the nonparametric Mann-Whitney H test was applied to achieve
the same objective.
P  0.01 was considered statistically significant in each situation. The
null hypothesis of means (or median) equality was refused.
Differences between frequencies in the subgroups of infertile men
were quantified using Fisher’s exact test.
Results
POLG allele and genotype distribution in the two
study populations
The most frequently observed POLG allele in both groups
of subjects was the common allele of 10 CAG repeats with a
frequency of 85% in the infertile and 81% in the control
group. We found a number of other not10 CAG alleles (mu-
tated alleles) ranging from seven to 12 in the infertile group
and from five to 12 in the control group (Table 1).
The combination of these alleles gave origin to three dif-
ferent genotypes: 10/10 CAG (homozygous wild type), 10/
not10 CAG (heterozygous), and not10/not10 CAG (homozy-
gous mutant). Some of the allele combinations such as 11/7
CAG were specifically found only in the infertile group,
whereas others (10/5, 10/7, 10/9, and 9/12) were found in
the control normospermic group (Fig. 1B)
In 10 cases, DNA extracted from both peripheral lympho-
cytes and spermatozoa was tested. The CAG genotype was
the same, excluding de novo tissue-specific mutations.
TABLE 1. Allelic frequency of the POLG gene CAG repeats in the
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A similar distribution of the three different POLG geno-
types has been observed in both groups. The most frequent
genotype in the infertile and control group was the homozy-
gous wild type (10/10CAG), 73.3 and 66.3%, followed by the
heterozygous (10/not10 CAG), 24.1 and 30.5%, and the ho-
mozygous mutant genotype (not10/not10 CAG), 2.6 and
3.2%, respectively (Fig. 1A).
In contrast to the paper by Rovio et al. (27), the homozy-
gous mutant genotype was not an exclusive feature of the
patient group but was found also in the normospermic
group, at a similar frequency (2.6 vs. 3.2%; P  not
significant).
POLG genotype distribution in subgroups of
infertile patients
The group of infertile patients included men with different
sperm parameters ranging from azoospermia to asthenotera-
tozoospermia. The frequency of the three POLG genotypes
has been calculated for four different subgroups: azoosper-
mic (n  50), cryptozoospermic (n  25), severe oligozo-
ospermic (n  72), and mixed moderate oligospermic and
asthenoteratozoospermic men (n  48). In all subgroups, the
most frequent genotype was the homozygous wild type,
followed by the heterozygous mutant. No homozygous mu-
FIG. 1. POLG gene CAG genotype in patients and controls. A, Combination of different CAG alleles in patients and in normospermic controls.
B, Genotype frequencies of the POLG gene in infertile and in normospermic men. W/W genotype indicates the presence of two common alleles
(10/10 CAG); W/M genotype indicates heterozygosity for the common allele (10 CAG) and for a mutated not10CAG allele ( or 10 CAG); M/M
genotype indicates homozygosity for the not10CAG allele ( or 10 CAG). Some of the combinations are specific for the patient group, whereas
others are specific for the control group.
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tant was found in the group of cryptozoospermic men; how-
ever, the relevance of this finding is of limited value due to
the size of this subgroup (n  25). The frequency of the
homozygous mutant genotype in the remaining three groups
(azoospermic, severe oligospermic, and mixed moderate
oligo-asthenoteratospermic men) was 2, 2.8, and 4.2%, re-
spectively. The relatively high frequency in the moderate
oligospermic and asthenoteratospermic group (4.2%) was
not statistically different from the control group (3.2%).
Genotype-phenotype correlation
A total of 11 homozygous mutants have been found in the
two study populations (Table 2). The sperm concentration
ranged from azoospermia to 85 million spermatozoa/ml.
Therefore, the previously suggested genotype-phenotype
correlation (mutant genotype and moderate oligozoosper-
mia) has not been confirmed in our study. Three of the six
normospermic men had conceived at least one child, which
indicates that spermatozoa bearing the mutant genotype are
fully fertile. The remaining three normospermic individuals
had not yet attempted conception.
Comparison of sperm parameters among patients with
different POLG genotype
To assess whether different POLG genotypes are able to
influence spermatogenesis or sperm function, we compared
the mean values of the three principal sperm parameters
(concentration, morphology, and motility) among men bear-
ing the three different genotypes. The mean values of the
three parameters were not significantly different among the
three groups in both normospermic and infertile men (Table 3).
Discussion
The search for new genetic anomalies represents one of the
major tasks in modern andrology because it is expected that
the majority of the so-called idiopathic cases of male infer-
tility are of genetic origin. Although the number of spermat-
ogenesis candidate genes is steadily increasing, their patho-
genetic role, i.e. the frequency and the associated phenotype
of their mutations, is largely unknown. To date, only two
genetic tests became part of the routine genetic analysis of
oligospermic and nonobstructive azoospermic men: karyo-
typing and Y chromosome microdeletion screening. Al-
though karyotype anomalies and AZF microdeletions are
frequently (30%) found in nonobstructive azoospermic
men, their incidence is much lower (10%) in oligospermic
patients. On the other hand, some of the known andrological
pathologies causing male infertility such as varicocele, cryp-
torchidism, or environmental toxins (for example, heavy
smoking) are associated with different degrees of spermat-
ogenic damage in different individuals, indicating the im-
portance of interaction between environment and genetic
background.
Recently, the role of polymorphisms in genes potentially
involved in spermatogenesis became of increasing interest.
Polymorphisms are supposed to be cofactors rather than
specific causes of spermatogenic failure because they are also
present in normospermic men, although at a lower fre-
quency. These types of genetic variants by themselves would
probably be responsible for a relatively mild impairment of
sperm production and/or function, but the effects of these
variants may be worsened by the presence of other cofactors.
TABLE 2. Seminal parameters observed in subjects with M/M
(not10/not10CAG) POLG genotype
Genotype Sperm no.  106/ml Motility(%)
Morphology
(%)
Patient A54 11/12 0.8 6 0
Patient A102 11/7 15.5 17 12
Patient A122 11/11 0
Patient A146 7/11 3.6 9 15
Patient A202 11/11 10 13 20
Control C52 11/11 85 57 34
Control C60 11/11 74.4 55 33
Control mm26 11/11 42 56 45
Control CS14 11/12 75 85 38
Control mm100 11/12 60 52 43
Control mm85 9/12 38 51 50
The “mutated genotype” has been found in both normospermic
controls and patients with a variety of sperm parameters ranging
from azoospermia (A122) to moderate oligoasthenoteratozoospermia
(A102).
TABLE 3. Mean  SD of the three semen parameters: sperm concentration/ml, percentage of spermatozoa with normal morphology
(Morphology %), and percentage of spermatozoa with rapid and slow progressive motility (Motility %) in the group of infertile patients and
in the group of normospermic men
Genotype W/W Genotype W/M Genotype M/M
Infertile patients
Sperm concentration/ml (106/ml) 4.09  7.43 6.95  16.59 5.98  6.61
n  143 n  47 n  5
Morphology (%) 13.03  9.07 11.68  7.95 11.25  4.78
n  85 n  31 n  4
Motility (%) 21.56  14.47 20.70  16.61 11.75  4.25
n  77 n  30 n  4
Normospermic controls
Sperm concentration/ml (106/ml) 80  48.95 87.59  75.27 62.40  19.13
n  126 n  58 n  6
Morphology (%) 40.08  7.53 41.17  8.43 40.50  6.65
n  126 n  58 n  6
Motility (%) 60.94  9.89 59.21  8.25 59.33  12.78
n  126 n  58 n  6
The comparison of the mean values among the three genotypes (W/W vs. W/M and W/W vs. M/M and W/M vs. M/M) in both groups gives
P  0.01 (not significant).
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The majority of data are originating from single studies (19–
22) that necessitate further confirmation; however, some of
the polymorphisms have been extensively studied in differ-
ent populations (23). The most debated and controversial
issue concerns the polymorphic CAG repeat-length in the
first exon of the androgen receptor. Different repeat length
leads to differences in the androgen receptor’s transactivat-
ing capacity (30), and it would affect the spermatogenic pro-
cess given its dependency on androgens. In some studies, an
increased length of the CAG repeat (still in the polymorphic
range) has been reported to be associated with male infer-
tility and in particular a cutoff value of more than 26 CAG
repeats (specific for infertile patients) has been reported (31).
These data have not been confirmed in other publications
(23, 32).
In the present study, we reported a similar discrepancy in
respect to previous data from Rovio et al. (27) and from
another very recent paper (33). Although Rovio et al. (27)
indicated a clear cause-effect relationship (and not a simple
association) between the presence of a homozygous mutant
genotype of the POLG gene and idiopathic oligospermia
with a calculated frequency of 5–10%, we did fail to confirm
such a finding. The mutated not10/not10 CAG genotype has
been found at the same frequency in both infertile and control
normospermic men. Moreover, the mean values of the three
principal sperm parameters (number, motility, and morphol-
ogy) did not differ significantly between carriers of the three
different genotypes (10/10, 10/not10, and not10/not10). The
recent paper on a Danish population (33) reports a signifi-
cantly higher frequency of the mutated genotype in normo-
spermic men affected by unexplained couple infertility. Al-
though the total number of patients and controls analyzed is
large, the main clinical conclusion is based on the comparison
of a small subgroup of normospermic patients (n  49) vs. a
large subgroup of controls with the same semen profile (total
n  572). Apart from the size of the patient’s subgroup, there
is also a problem with the selection criteria used to define it
because the presence of functional female factors cannot be
completely ruled out with the standard diagnostic exams and
thus the couple’s infertility can be related, with the same
likelihood, to a functional female component as well as to a
functional male factor. Moreover, six of seven normospermic
patients with the mutated POLG genotype are in fact asthe-
nozoospermic (sperm motility  50%); thus, the true fre-
quency of homozygous mutant genotype would be one of 43
(2%) instead of seven of 49 (14.3%), which is similar to that
found in the controls. Therefore, the author’s conclusion
about the association between reduced sperm fertilizing abil-
ity and POLG polymorphism is questionable.
The effect, if any, of the not10/not10 CAG genotype on the
polymerase’s activity is poorly understood. It is well known
that human mtDNA encodes 13 of the polypeptides of the
electron transport chain associated with the process of oxi-
dative phosphorylation, the spermatozoa’s most important
ATP-generating pathway. Although both point mutations
(34) and multiple large-scale deletions (35) of mtDNA have
been reported in men with poor semen quality, their clinical
significance is not yet clearly defined. In addition, an asso-
ciation between asthenozoospermia and certain mtDNA
haplogroups that reflect significant differences in sperm ox-
idative performance has also been observed (22). Rovio et al.
(27) proposed a reduced efficiency of the polymerase  in the
presence of homozygous mutated polyglutamine tract,
which would lead to the accumulation of mtDNA mutations
and impaired sperm energy metabolism and spermatogenic
dysfunction. Although in vitro studies in cultured HEK293T
cells failed to reveal a detectable effect of the deletion of the
polyglutamine tract on enzymatic activity of the polymerase
 (36), the authors hypothesized that a sperm-specific protein
could eventually interact with this region of POLG, and the
interaction could be negatively influenced by the not10 CAG
repeat length. The identification of this partner protein and
the confirmation of the hypothesized increased rate of
mtDNA mutations in association with the mutated POLG
genotype is awaited.
Discrepancy between the first and subsequent studies are
frequently observed for case-control genetic association
studies, and both bias and genuine population diversity may
explain the overestimation of the disease protection or pre-
disposition conferred by a genetic polymorphism.
In the case of POLG polymorphism, both conditions may
contribute to the observed discrepancy. One possible expla-
nation could be that polymorphisms with mild functional
effects (and this should still be demonstrated in the case of
POLG polymorphism) would be of pathogenetic significance
only in the presence of specific environmental factors or in
association with a certain genetic background.
Apart from different ethnic and geographic origin, other
factors related to the study populations (size and selection
criteria) may give another plausible explanation for the dis-
cordance. An ideal control group for studies dealing with
male infertility should contain normospermic-proven fertile
men because around 10% of fertile men are oligospermic, and
functional sperm defects rarely coexist with normal sperm
parameters. However, because the putative effect of the
POLG mutation is oligo/astheno/teratozoospermia, to
avoid selection bias we selected our control group on the
basis of their normal semen parameters. Although fertility
was not assessed in about half of the control cases, three of
six control men bearing the homozygous mutation were both
normospermic and fertile. This finding clearly shows that
spermatozoa from these men are fully fertile.
The most likely explanation for the observed discrepancy
between our data and the paper from Rovio et al. (27) is the
relatively low number of controls in their study (n  98) vs.
a much larger group (n  190) in our study. Ioannidis et al.
(37) have recently evaluated by meta-analysis 370 studies
addressing 36 genetic associations for various outcomes of
disease. They demonstrated that the small size (with a critical
sample size of 150) of the first publication and a large
number of studies were independent predictors of reaching
discrepancies.
In conclusion, our study failed to confirm any influence of
the CAG repeat length of the POLG gene on the principal
sperm parameters. More importantly, considering that the
homozygous mutant genotype has been found at the same
frequency in normospermic men as in infertile patients, the
analysis of the CAG repeat tract of the POLG gene does not
appear to have any clinical diagnostic value.
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